Inscrit le: 10 Nov 2010
|Posté le: Jeu 23 Déc - 04:32 (2010) Sujet du message: FDA Files New Appeal in E-Cigarette Lawsuit
|FDA Files New Appeal in E-Cigarette Lawsuit
The Food and Drug Administration, dealt a blow this month in its effort to regulate electronic cigarettes as drug devices, isn't walking away from the fight.
The agency on Monday filed a petition to ask the entire U.S. Court of Appeals for the District of Columbia Circuit to hold a new hearing and review the FDA's appeal, which was rejected Dec. 7 by a three-judge panel.
At issue is how the FDA should regulate a nascent industry whose products have caught on with thousands of smokers who are seeking an alternative to their daily habit. E-cigarettes are battery-powered tubes that turn nicotine-filled liquid into a vapor mist.Good switching power supply will make your work easier.
The appellate panel ruled that e-cigarettes should be regulated as tobacco products by the FDA, unless marketers make specific claims that the devices help smokers quit or provide other remedies.
The agency contends that electronic cigarettes are drug or medical devices that require preapproval from the FDA, much like nicotine gums, patches or sprays. The agency began intercepting shipments of e-cigarettes from China two years ago, which triggered a lawsuit by the fledgling industry.
Sottera Inc., an Arizona e-cigarette distributor that joined the lawsuit as a plaintiff and some of its rivals say their products are merely recreational alternatives to cigarettes and that they haven't marketed them as tools to wean people off nicotine. The industry's annual sales are estimated at more than $100 million.
The appeals panel upheld a January ruling by a district judge, who granted a preliminary injunction to the e-cigarette distributors who sued the FDA.Seo service will improve the ranking of your website in the search engine.
On Monday, the agency asked the full appellate court to reinstate a stay of the preliminary injunction, pending its request for a rehearing of the case.
In its court papers, the FDA argues that the three-judge panel's decision "rests on a clear error of law and will undermine" objectives that were laid out by Congress when it passed legislation in 2009 that empowered the FDA to regulate tobacco products for the first time.